中国药品集中采购的演变以及与医保支付的逻辑关系

发布时间：2018-06-07 10:47

本文选题：药品集中采购 + 医保支付　；参考：《中国卫生政策研究》2017年06期

【摘要】：本文主要通过政策梳理和文献回顾的方法,详细阐述了药品集中采购政策的发展演变及其与医保支付的逻辑关系。文章首先梳理了药品集中采购的三个发展阶段,并分析了当前药品集中招标采购的特点和趋势;进而重点探讨了药品集中采购与医保支付体系的关系以及两者配套改革对于解决药品问题的现实可行性。研究认为,药品集中招标采购已经演变为省级平台限价下的议价、最低价联动采购方式;药品集中招标采购可为医保支付标准的形成提供依据,但国家药品谈判以及省级医保特药谈判存在功能重叠;药品招标采购、医保支付等制度安排可助推医药分开,配套相关改革可为解决"药价虚高"提供一种思路。
[Abstract]:Through the methods of policy combing and literature review, this paper expounds in detail the development and evolution of centralized drug procurement policy and its logical relationship with medical insurance payment. The article first combs the three development stages of centralized drug procurement, and analyzes the characteristics and trends of the current centralized procurement of drugs; Furthermore, the relationship between centralized drug procurement and medical insurance payment system and the feasibility of the corresponding reform in solving the drug problem are discussed. The research shows that centralized bidding for drugs has evolved into a negotiated price under the price limit of the provincial platform, and the lowest price is linked to the purchase method; the centralized bidding for drugs can provide the basis for the formation of the standard of payment for medical insurance. However, the national drug negotiation and the provincial medical insurance special drug negotiation have overlapping functions, the system arrangement of drugs bidding and purchasing, medical insurance payment and so on can promote the separation of medicine, and the related reform can provide a way of thinking to solve the problem of "false drug price".
【作者单位】：中国社会科学院研究生院;
【分类号】：R95

【参考文献】